371 related articles for article (PubMed ID: 28232016)
1. Macrophage Apoptosis and Necrotic Core Development in Atherosclerosis: A Rapidly Advancing Field with Clinical Relevance to Imaging and Therapy.
Gonzalez L; Trigatti BL
Can J Cardiol; 2017 Mar; 33(3):303-312. PubMed ID: 28232016
[TBL] [Abstract][Full Text] [Related]
2. The walking dead: macrophage inflammation and death in atherosclerosis.
Kavurma MM; Rayner KJ; Karunakaran D
Curr Opin Lipidol; 2017 Apr; 28(2):91-98. PubMed ID: 28134664
[TBL] [Abstract][Full Text] [Related]
3. Macrophage apoptosis in atherosclerosis: consequences on plaque progression and the role of endoplasmic reticulum stress.
Tabas I
Antioxid Redox Signal; 2009 Sep; 11(9):2333-9. PubMed ID: 19243235
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms and consequences of efferocytosis in advanced atherosclerosis.
Thorp E; Tabas I
J Leukoc Biol; 2009 Nov; 86(5):1089-95. PubMed ID: 19414539
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms and consequences of macrophage apoptosis in atherosclerosis.
Seimon T; Tabas I
J Lipid Res; 2009 Apr; 50 Suppl(Suppl):S382-7. PubMed ID: 18953058
[TBL] [Abstract][Full Text] [Related]
6. The atherosclerotic plaque vulnerability: focus on the oxidative and endoplasmic reticulum stress in orchestrating the macrophage apoptosis in the formation of the necrotic core.
Cominacini L; Garbin U; Mozzini C; Stranieri C; Pasini A; Solani E; Tinelli IA; Pasini AF
Curr Med Chem; 2015; 22(13):1565-72. PubMed ID: 25760090
[TBL] [Abstract][Full Text] [Related]
7. Assessing Efferocytosis in Atherosclerotic Lesions In Situ.
Yurdagul A
Methods Mol Biol; 2022; 2419():561-567. PubMed ID: 35237988
[TBL] [Abstract][Full Text] [Related]
8. Macrophage autophagy plays a protective role in advanced atherosclerosis.
Liao X; Sluimer JC; Wang Y; Subramanian M; Brown K; Pattison JS; Robbins J; Martinez J; Tabas I
Cell Metab; 2012 Apr; 15(4):545-53. PubMed ID: 22445600
[TBL] [Abstract][Full Text] [Related]
9. Macrophage proliferation and apoptosis in atherosclerosis.
Andrés V; Pello OM; Silvestre-Roig C
Curr Opin Lipidol; 2012 Oct; 23(5):429-38. PubMed ID: 22964992
[TBL] [Abstract][Full Text] [Related]
10. Targeting macrophage necroptosis for therapeutic and diagnostic interventions in atherosclerosis.
Karunakaran D; Geoffrion M; Wei L; Gan W; Richards L; Shangari P; DeKemp EM; Beanlands RA; Perisic L; Maegdefessel L; Hedin U; Sad S; Guo L; Kolodgie FD; Virmani R; Ruddy T; Rayner KJ
Sci Adv; 2016 Jul; 2(7):e1600224. PubMed ID: 27532042
[TBL] [Abstract][Full Text] [Related]
11. CAMKIIγ suppresses an efferocytosis pathway in macrophages and promotes atherosclerotic plaque necrosis.
Doran AC; Ozcan L; Cai B; Zheng Z; Fredman G; Rymond CC; Dorweiler B; Sluimer JC; Hsieh J; Kuriakose G; Tall AR; Tabas I
J Clin Invest; 2017 Nov; 127(11):4075-4089. PubMed ID: 28972541
[TBL] [Abstract][Full Text] [Related]
12. The Role of Efferocytosis in Atherosclerosis.
Kojima Y; Weissman IL; Leeper NJ
Circulation; 2017 Jan; 135(5):476-489. PubMed ID: 28137963
[TBL] [Abstract][Full Text] [Related]
13. Protective Functions of Liver X Receptor α in Established Vulnerable Plaques: Involvement of Regulating Endoplasmic Reticulum-Mediated Macrophage Apoptosis and Efferocytosis.
Che X; Xiao Q; Song W; Zhang H; Sun B; Geng N; Tao Z; Shao Q; Pu J
J Am Heart Assoc; 2021 May; 10(10):e018455. PubMed ID: 33969692
[TBL] [Abstract][Full Text] [Related]
14. Macrophage Death as a Pharmacological Target in Atherosclerosis.
Martinet W; Coornaert I; Puylaert P; De Meyer GRY
Front Pharmacol; 2019; 10():306. PubMed ID: 31019462
[TBL] [Abstract][Full Text] [Related]
15. Efferocytosis in atherosclerotic lesions: Malfunctioning regulatory pathways and control mechanisms.
Tajbakhsh A; Rezaee M; Kovanen PT; Sahebkar A
Pharmacol Ther; 2018 Aug; 188():12-25. PubMed ID: 29444453
[TBL] [Abstract][Full Text] [Related]
16. Macrophage Apoptosis and Efferocytosis in the Pathogenesis of Atherosclerosis.
Linton MF; Babaev VR; Huang J; Linton EF; Tao H; Yancey PG
Circ J; 2016 Oct; 80(11):2259-2268. PubMed ID: 27725526
[TBL] [Abstract][Full Text] [Related]
17. K-80003 Inhibition of Macrophage Apoptosis and Necrotic Core Development in Atherosclerotic Vulnerable Plaques.
Wang X; Sun Z; Yuan R; Zhang W; Shen Y; Yin A; Li Y; Ji Q; Wang X; Li Y; Zhang M; Pan X; Shen L; He B
Cardiovasc Drugs Ther; 2022 Dec; 36(6):1061-1073. PubMed ID: 34410548
[TBL] [Abstract][Full Text] [Related]
18. Reversal of hypoxia in murine atherosclerosis prevents necrotic core expansion by enhancing efferocytosis.
Marsch E; Theelen TL; Demandt JA; Jeurissen M; van Gink M; Verjans R; Janssen A; Cleutjens JP; Meex SJ; Donners MM; Haenen GR; Schalkwijk CG; Dubois LJ; Lambin P; Mallat Z; Gijbels MJ; Heemskerk JW; Fisher EA; Biessen EA; Janssen BJ; Daemen MJ; Sluimer JC
Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2545-53. PubMed ID: 25256233
[TBL] [Abstract][Full Text] [Related]
19. Dead cell and debris clearance in the atherosclerotic plaque: Mechanisms and therapeutic opportunities to promote inflammation resolution.
Dhawan UK; Singhal A; Subramanian M
Pharmacol Res; 2021 Aug; 170():105699. PubMed ID: 34087352
[TBL] [Abstract][Full Text] [Related]
20. Potential Mechanisms and Effects of Efferocytosis in Atherosclerosis.
Wang L; Li H; Tang Y; Yao P
Front Endocrinol (Lausanne); 2020; 11():585285. PubMed ID: 33597922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
